CAJ | 학술논문

目的：探析腔镜微创手术在肺癌患者中的应用效果及对患者术后肺功能所造成影响。方法以我院2009年2月至2014年10月期间收治60例肺癌患者进行研究，分为两组。对照组行开胸手术，观察组行腔镜微创手术，比较两组患者淋巴结清扫数目、术后拔管日、术后疼痛评分、住院时间及术后一个月肺功能指标恢复情况。结果两组淋巴结清扫数目接近（P＞0．05），对比无显著差异；观察组术后拔管时间及住院时间分别为（3．4±0．6）天和（8．2±2．1）天，均明显比对照组更短（P＜0．05），术后疼痛评分观察组显著低于对照组，比较有统计学意义。两组患者术前各项肺功能指标之间的比较无明显差异（P＞0．05），手术后观察组FVC、FEV1及FEV1／FVC等指标恢复情况显著优于对照组（P＜0．05），比较差异显著。结论应用腔镜微创手术治疗肺癌患者可减轻手术创伤，促进术后肺功能的恢复，同时加快康复进度，临床价值高。
목적：탐석강경미창수술재폐암환자중적응용효과급대환자술후폐공능소조성영향。방법이아원2009년2월지2014년10월기간수치60례폐암환자진행연구，분위량조。대조조행개흉수술，관찰조행강경미창수술，비교량조환자림파결청소수목、술후발관일、술후동통평분、주원시간급술후일개월폐공능지표회복정황。결과량조림파결청소수목접근（P＞0．05），대비무현저차이；관찰조술후발관시간급주원시간분별위（3．4±0．6）천화（8．2±2．1）천，균명현비대조조경단（P＜0．05），술후동통평분관찰조현저저우대조조，비교유통계학의의。량조환자술전각항폐공능지표지간적비교무명현차이（P＞0．05），수술후관찰조FVC、FEV1급FEV1／FVC등지표회복정황현저우우대조조（P＜0．05），비교차이현저。결론응용강경미창수술치료폐암환자가감경수술창상，촉진술후폐공능적회복，동시가쾌강복진도，림상개치고。
Objective To explore the application effect of minimally invasive operation in patients with lung cancer and impact of prolonged postoperative lung function.Methods Researched 60 cases of patients with lung cancer in our hospital from February 2009 -October 2014 year, were divided into two groups.The control group underwent open chest surgery, observation group of endoscopic minimally invasive surgery, compared two groups of patients with number lymph node cleaning, extubation dsays, The score of postoperative pain , lung function indices recovery situation in postoperative after a month.Results The number of lymph node dissection of two groups approach (P>0.05), with no significant difference; Observation group after extubation time and hospitalization time were (3.4 ±0.6) days and (8.2 ±2.1) days, significantly shorter than control group (P<0.05), difference was statistically significant.The score in postoperative was significantly lower than the control group, had significant difference (P>0.05), after the surgery, recovery situation of FVC, FEV1 and FEV1/FVC in observation group were increased significantly than in control group ( P <0.05 ) , difference was significant.Conclusions The application of minimally invasive surgical in treatment of lung cancer patients can reduce the surgical trauma, promote the postoperative pulmonary function recovery, at the same time to speed up the recovery progress with high clinical value.